scholarly journals Stellate Ganglion Blockade and Left Cardiac Sympathetic Denervation With Left Stellate Ganglionectomy in a Patient With Refractory Electrical Storm: A Case Report

Cureus ◽  
2020 ◽  
Author(s):  
Nformbuh V Asangmbeng ◽  
Dominiq Okoduwa ◽  
Erskine A James
Keyword(s):  
Case Report ◽  
Stellate Ganglion ◽  
Sympathetic Denervation ◽  
Electrical Storm ◽  
Left Cardiac Sympathetic Denervation ◽  
Stellate Ganglion Blockade ◽  
Cardiac Sympathetic Denervation

Stellate ganglion blockade for electrical storm: a case report

2020 ◽  
Vol 34 ◽  
pp. S17-S18
Author(s):  
C. Nigro Neto ◽  
D.A. Ribeiro Moreira ◽  
F.J. Lucena Bezerra ◽  
B. Valdigem ◽  
B. Cesconetto Coutinho ◽  
...  
Keyword(s):  
Case Report ◽  
Stellate Ganglion ◽  
Electrical Storm ◽  
Stellate Ganglion Blockade

scholarly journals Bilateral Cardiac Sympathetic Denervation on an ECMO patient for Refractory Ventricular arrhythmia: A Case Report.

2021 ◽  
Author(s):  
Akram Farran ◽  
Daniel Farinas Lugo ◽  
Joseph Boyer
Keyword(s):  
Case Report ◽  
Brugada Syndrome ◽  
Ventricular Arrhythmias ◽  
Stellate Ganglion ◽  
Sympathetic Denervation ◽  
Definitive Treatment ◽  
Genetic Syndromes ◽  
Ecmo Patient ◽  
History Of ◽  
Cardiac Sympathetic Denervation

Genetic syndromes such as Brugada syndrome can lead to lethal ventricular arrhythmias. Cardiac Sympathetic Denervation has been shown to be effective in ameliorating refractory ventricular arrhythmias. We present a 33-year-old black female with a past medical history of Brugada syndrome with an implantable cardiac defibrillator (ICD), who presented with refractory ventricular tachycardia/atrial fibrillation leading to cardiogenic shock, requiring Extracorporeal membrane oxygenation (ECMO). The patient subsequently underwent bilateral stellate ganglion sympathetic denervation in the setting of refractory ventricular arrhythmias. We present this case report to showcase that thoracoscopic bilateral cardiac sympathetic denervation can be an effective definitive treatment option for ventricular arrhythmias refractory to medical management.

Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias

2017 ◽  
Vol 28 (8) ◽  
pp. 903-908 ◽  
Author(s):  
Ricardo Cardona-Guarache ◽  
Santosh K. Padala ◽  
Luis Velazco-Davila ◽  
Anthony Cassano ◽  
Antonio Abbate ◽  
...  
Keyword(s):  
Ventricular Arrhythmias ◽  
Stellate Ganglion ◽  
Sympathetic Denervation ◽  
Life Threatening ◽  
Stellate Ganglion Blockade ◽  
Cardiac Sympathetic Denervation

scholarly journals Re-do left cardiac sympathetic denervation (LCSD following breakthrough cardiac events in long qt syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT)

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
J Bos ◽  
K.B Sorensen ◽  
C Moir ◽  
M.J Ackerman
Keyword(s):  
Stellate Ganglion ◽  
Minimally Invasive Therapy ◽  
Sympathetic Denervation ◽  
Polymorphic Ventricular Tachycardia ◽  
Sympathetic Chain ◽  
Incomplete Resection ◽  
Cardiac Events ◽  
Left Cardiac Sympathetic Denervation ◽  
Qt Syndrome ◽  
Cardiac Sympathetic Denervation

Abstract Background Left cardiac sympathetic denervation (LCSD) is an effective anti-fibrillatory, minimally invasive therapy for patients with either LQTS or CPVT. As a pre-ganglionic fiber resection, re-growth or re-innervation is not possible. However, if a suboptimal CSD was performed, chances for post-LCSD breakthrough cardiac events (BCEs) are increased. Purpose To examine the prevalence and outcomes of patients requiring a re-do LCSD. Methods We performed a retrospective review of the 251 LQTS and CPVT patients who underwent CSD (mostly LCSD) at our institution to identify the subset referred for additional CSD because of recurrent BCEs after their primary LCSD that was performed elsewhere. Clinical data on symptomatic status prior to diagnosis and BCEs after first surgery as well as the surgical reports were reviewed to determine the reasons for the repeat procedure. Results Among the 15 patients (6% overall, 6 female; 13 LQTS, 2 CPVT) referred for additional CSD, 3 patients (20%) had a re-do LCSD performed instead of a sequential RCSD because of incomplete resection with the primary LCSD. Patient 1 is a male with Jervell-and-Lange Nielsen Syndrome (JLNS; KCNQ1-K421fs9X; KCNQ1-N365H), who first experienced syncope with torsades at age 3 after which a primary bilateral CSD was performed elsewhere. He had 2 BCEs and at age 12 underwent re-do LCSD, where his left-sided T2-T4 sympathetic chain with remnants of T1 were found to be intact. Patient 2 is a male who had 3 cardiac events prior to diagnosis (genotype negative LQTS) and LCSD at age 3. Following 3 BCEs, he underwent re-do LCSD at age 5 where scarring of T3 and intact stellate ganglion were found. Patient 3 is an adult female with CPVT (RYR2-deletion exon 3) who had multiple syncopal events, out-of-hospital arrest (leading to ICD) and 2 ICD-storms before primary bilateral CSD. Re-do LCSD was performed after identifying an intact left stellate ganglion and T2. Conclusions Before performing a primary bilateral CSD, proceeding to a RCSD after post-LCSD BCEs, or doing a videoscopic LCSD in the first place, it must be recognized that LCSD's success hinges on fully resecting the lower half of the stellate ganglion and the sympathetic chain through T4. Anything less is a partial denervation and likely ineffective procedure. Funding Acknowledgement Type of funding source: None

scholarly journals Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes

2014 ◽  
Vol 22 (4) ◽  
pp. 160-166 ◽  
Author(s):  
L. R. A. Olde Nordkamp ◽  
A. H. G. Driessen ◽  
A. Odero ◽  
N. A. Blom ◽  
D. R. Koolbergen ◽  
...  
Keyword(s):  
The Netherlands ◽  
Sympathetic Denervation ◽  
Inherited Arrhythmia ◽  
Left Cardiac Sympathetic Denervation ◽  
Cardiac Sympathetic Denervation
Sign in / Sign up

Export Citation Format

Share Document